First Trust Advisors LP Grifols Sa Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $2.33 Million - $3.5 Million	302,380 Added 6.9%	4,684,749 $54.2 Million
Q3 2023 Nov 13, 2023	SELL	$8.91 - $10.91 $18.4 Million - $22.6 Million	-2,067,420 Reduced 32.05%	4,382,369 $40.1 Million
Q2 2023 Aug 14, 2023	BUY	$7.14 - $9.29 $6.15 Million - $8 Million	861,168 Added 15.41%	6,449,789 $59.1 Million
Q1 2023 May 15, 2023	SELL	$6.65 - $10.69 $11 Million - $17.7 Million	-1,653,438 Reduced 22.83%	5,588,621 $41.2 Million
Q4 2022 Feb 09, 2023	BUY	$5.96 - $8.53 $17.1 Million - $24.5 Million	2,869,022 Added 65.61%	7,242,059 $61.6 Million
Q3 2022 Nov 14, 2022	SELL	$5.95 - $14.3 $684,850 - $1.65 Million	-115,101 Reduced 2.56%	4,373,037 $26.9 Million
Q2 2022 Aug 12, 2022	BUY	$10.6 - $13.28 $6.12 Million - $7.67 Million	577,763 Added 14.78%	4,488,138 $53.3 Million
Q1 2022 May 13, 2022	SELL	$10.37 - $12.73 $2.4 Million - $2.94 Million	-231,084 Reduced 5.58%	3,910,375 $45.7 Million
Q4 2021 Feb 08, 2022	BUY	$10.21 - $15.27 $2.4 Million - $3.59 Million	235,120 Added 6.02%	4,141,459 $46.5 Million
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $6.47 Million - $7.96 Million	460,091 Added 13.35%	3,906,339 $57.1 Million
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $4.12 Million - $4.7 Million	-248,107 Reduced 6.72%	3,446,248 $59.8 Million
Q1 2021 May 14, 2021	BUY	$15.15 - $19.78 $3.93 Million - $5.13 Million	259,477 Added 7.55%	3,694,355 $63.9 Million
Q4 2020 Feb 02, 2021	SELL	$16.86 - $19.67 $5.3 Million - $6.18 Million	-314,187 Reduced 8.38%	3,434,878 $63.3 Million
Q3 2020 Nov 05, 2020	BUY	$15.4 - $20.16 $9.7 Million - $12.7 Million	629,650 Added 20.18%	3,749,065 $65 Million
Q2 2020 Jul 22, 2020	BUY	$18.24 - $21.45 $13 Million - $15.2 Million	710,335 Added 29.49%	3,119,415 $56.9 Million
Q1 2020 May 06, 2020	SELL	$16.28 - $25.63 $656,995 - $1.03 Million	-40,356 Reduced 1.65%	2,409,080 $48.5 Million
Q4 2019 Feb 03, 2020	SELL	$19.57 - $23.52 $5.66 Million - $6.8 Million	-289,209 Reduced 10.56%	2,449,436 $57 Million
Q3 2019 Nov 04, 2019	SELL	$19.85 - $22.76 $46.4 Million - $53.2 Million	-2,335,265 Reduced 46.02%	2,738,645 $54.9 Million
Q2 2019 Jul 30, 2019	SELL	$17.59 - $21.1 $911,320 - $1.09 Million	-51,809 Reduced 1.01%	5,073,910 $107 Million
Q1 2019 May 09, 2019	BUY	$18.01 - $20.11 $8.16 Million - $9.11 Million	453,032 Added 9.7%	5,125,719 $103 Million
Q4 2018 Feb 07, 2019	BUY	$17.44 - $21.53 $661,638 - $816,805	37,938 Added 0.82%	4,672,687 $85.8 Million
Q3 2018 Oct 25, 2018	BUY	$19.97 - $21.96 $42.7 Million - $47 Million	2,139,441 Added 85.74%	4,634,749 $99 Million
Q2 2018 Aug 02, 2018	BUY	$20.16 - $24.68 $10.6 Million - $13 Million	527,595 Added 26.81%	2,495,308 $53.6 Million
Q1 2018 Apr 23, 2018	BUY	$20.31 - $24.95 $1.81 Million - $2.23 Million	89,312 Added 4.75%	1,967,713 $41.7 Million
Q4 2017 Feb 08, 2018	BUY	$20.99 - $23.89 $1.42 Million - $1.61 Million	67,501 Added 3.73%	1,878,401 $43.1 Million
Q3 2017 Oct 24, 2017	BUY	$20.07 - $21.89 $36.3 Million - $39.6 Million	1,810,900	1,810,900 $39.6 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$165 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$156 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$96.8 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$87.2 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$84.2 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account